Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Severe psoriasis relapse following tralokinumab therapy for atopic dermatitis.

JAAD case reports·2026

Same author

An Update on Common Genodermatoses Not to be Missed.

Journal of drugs in dermatology : JDD·2026

Same author

Evaluation of Dermatology Procedure Perceptions and Seeking in LGBTQ+ Patients.

Journal of drugs in dermatology : JDD·2026

Same authorSame journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026

Same author

Response to van Rooij et al., "Clinical Context and Comparative Interpretation of Dermatologic Disease Burden in People With HIV in the Modern Antiretroviral Era".

Journal of the American Academy of Dermatology·2026

Same author

JAAD Game Changers: Early postoperative water exposure does not increase complications in cutaneous surgeries: a randomized, investigator-blinded, controlled trial.

Journal of the American Academy of Dermatology·2026

Search research articles

Related Experiment Video

Updated: Oct 1, 2025

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

mTOR Inhibitor-Induced Transient Acantholytic Dermatitis.

Dillon Nussbaum, L Glass, Adam Friedman

Journal of Drugs in Dermatology : JDD

|March 7, 2022

Summary

A patient with metastatic carcinoid experienced new, itchy skin rashes. This case highlights potential dermatologic manifestations in carcinoid syndrome.

Area of Science:

Dermatology
Oncology
Endocrinology

Background:

Carcinoid syndrome can manifest with various symptoms, including skin changes.
Metastatic carcinoid tumors, particularly from the small bowel, have potential for widespread effects.
Dermatologic presentations are not uncommon but require careful evaluation in the context of malignancy.

Observation:

Presented with new-onset, severely pruritic "breakouts" affecting the arms, neck, and chest.
The skin lesions were described as widespread and intensely itchy.

Findings:

The pruritic rash suggests a potential dermatological manifestation of carcinoid syndrome.
Further investigation is needed to confirm the link between the carcinoid tumor and the observed skin condition.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Related Experiment Videos

Last Updated: Oct 1, 2025

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Implications:

This case underscores the importance of considering carcinoid syndrome in patients with metastatic carcinoid tumors presenting with unexplained dermatological symptoms.
Early recognition and diagnosis of such cutaneous manifestations can aid in timely management and potentially improve patient outcomes.